作者: A S Pickard , T A Lee , C T Solem , M J Joo , G T Schumock
关键词:
摘要: A major priority for funding agencies and researchers involved in comparative-effectiveness research (CER) is to ensure that questions will produce findings are relevant feasible implement. In this article, we describe a process involving experts stakeholders identifying prioritizing CER studies, as illustrated by our experience chronic obstructive pulmonary disease (COPD). Clinical Pharmacology & Therapeutics (2011); 90 6, 888–892. doi:10.1038/clpt.2011.237